Roche Stock - Weekly review and pharma sector comparison
Published on 06/19/2026 at 17:02 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Edited by ad hoc news Sector & Peer-Group Desk. Verified prior to publication on 06/19/2026, 15:44 CET. Details in the imprint.
Roche Holding AG (CH0012032048) has moved broadly in line with the Swiss blue-chip universe this week. With no new ad-hoc statements or major analyst rating changes, investors are focusing on how the stock has fared against other large pharmaceutical names, according to recent exchange data.
All news and price data on Roche stock
Further background on Roche Holding AG, past market moves and regulatory disclosures can be found in the dedicated topic section for the stock.
How Roche traded this week
Roche Holding’s non-voting equity securities trade on the SIX Swiss Exchange under the ticker ROG, which remains the main liquidity line for international investors according to the Swiss exchange overview.
On Friday afternoon, Roche shares were quoted around CHF 319.00 in Zurich, implying a daily decline of roughly 2.7% and leaving the stock slightly lower over the past five trading sessions.
Weekly review and pharma sector lens
Over the week, Roche has underperformed the broader Swiss Market Index only marginally, with investors reassessing exposure to defensive healthcare names after a stronger start to the quarter.
Peer comparison shows that several large European pharmaceutical groups have also seen subdued or negative weekly returns, pointing to a broadly cautious stance on the sector rather than a company-specific signal.
What the company sells
Roche generates most of its revenue from prescription medicines in oncology, immunology, neuroscience and infectious diseases, complemented by a large diagnostics division that provides laboratory and point-of-care testing systems for hospitals and research centers worldwide.
Where the stock trades today
The shares of Roche Holding (CH0012032048) trade on the SIX Swiss Exchange at CHF 319.00 as of 06/19/2026, 14:44 CET.
Key facts on Roche stock
- Company: Roche Holding AG
- ISIN: CH0012032048
- WKN: 855167
- Ticker: ROG
- Venue: SIX Swiss Exchange
- Price (as of 06/19/2026, 14:44 CET): 319.00 CHF
- Market cap: 219,000,000,000 CHF (as of 06/19/2026)
- Sector / Industry: Health Care / Pharmaceuticals & Biotechnology
- Index membership: SMI, Stoxx Europe 50
- Next earnings date: not officially scheduled
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
